Maynard Um
-
-
-
-
-
-
-
Truist Securities Assumes Jazz Pharmaceuticals (JAZZ) at Buy
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $232 at Jefferies
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $230 at Truist Securities
-
-
-
-
-
-
-
Baird's Brian Skorney on Jazz Pharmaceuticals (JAZZ): 'We are buyers on weakness'
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $247 at BofA Securities
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $205 at Truist Securities
-
423,040 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

